GV was among the participants in the healthcare management platform developer's third round this year, valuing it at $1.5bn.

US-based healthcare management software producer Olive completed a $225m financing round yesterday that included GV, the corporate venturing subsidiary of internet technology group Alphabet formerly known as Google Ventures.

Hedge fund manager Tiger Global Management led the round, which also featured General Catalyst, Drive Capital, Silicon Valley Bank, Sequoia Capital Global Equities, Dragoneer Investment Group and Transformation Capital Partners.

The round valued the company at $1.5bn and doubled its funding to about $450m since it was founded as CrossChx in…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Robert Lavine

Robert Lavine is special features editor for Global Venturing.
Email LinkedIn